Our Mission

The Team Drea Foundation supports bold, innovative research to find a cure or effective treatment for ALS.

We see raising awareness about this devastating disease as an opportunity to inspire people to live bravely, love joyfully, and appreciate the gift of life.

Our Founder

Andrea Lytle Peet was diagnosed with ALS in 2014 at the age of 33. In eight months, she went from completing a 70.3-mile half Ironman triathlon to walking with a cane.

Remarkably, she has continued to participate in races on her recumbent trike. In May 2022, She became the first person with ALS to do a marathon in all 50 states!

Go On, Be Brave. Make A World Without ALS

States + Canada, and the U.K
Donations Raised

About ALS

Amyotrophic lateral sclerosis (aka ALS or Lou Gehrig’s disease) is a progressive neurological disease that affects the nerve cells in the brain and spinal cord. When motor neurons that connect nerves and muscles die, people lose the ability to initiate and control muscle movement. Without stimulation, muscles become weak and atrophy. Most people with ALS become totally paralyzed as they lose the ability to walk, talk, eat, swallow, and breathe.

Every 90 minutes, someone with ALS dies and another person is diagnosed.

The average age of diagnosis is 55; however, cases of ALS also appear in people in their 20s and 30s.

Military veterans are twice as likely to develop ALS as the general population. Athletes also seem to be more susceptible. No one is sure why.

The average life expectancy of a person with ALS is 2-5 years. 20% live 5 years or more; 10% percent live more than 10 years.

There is no effective treatment for ALS. The only approved drugs for ALS only slow down the decline by a few months.

2 weeks ago

Team Drea Foundation
A smattering of pics from my favorite 5k with some of my favorite people at my favorite place @solacoffee. All coming together to #endALS. Not soon enough for Jeanne, Dave, Cory, Duane, Dawn, or so many others, but we keep showing up and fighting with love and joy and sadness. 💜💚💪 ... See MoreSee Less
View on Facebook

2 weeks ago

Team Drea Foundation
Swallow #8 for me, swallow #1 for my dad! Thanks to @jcecil_tct for taking such good care of us and @flysquirrelfilms for documenting for #goonbebrave 💪 EXTRA special to have @jillyvjonnyb with us for her own swallow tat 🤗 ... See MoreSee Less
View on Facebook

2 weeks ago

Team Drea Foundation
Parexel is reaching out to patients to help design clinical trials — what a novel idea! Happy & honored to be on their Patient Advisory Council, though I learn WAY more than I contribute. We’re all working towards the same goal 💚📷: @flysquirrelfilmsTo help us better understand our patients, we asked Andrea Peet, former clinical trial participant, member of our North American Patient Advocacy Council (PAC) and founder of the nonprofit Team Drea Foundation — which has raised more than $850,000 for ALS research to date — for her thoughts on how she would design more patient-centric clinical trials. Read her insights below or click to read her full story: www.parexel.com/company/patient-stories/andrea-and-davids-storyIf you've participated in a clinical trial, we want to hear from you! Comment below on how we can make trials better for patients.#PersonBehindthePatient #ParexelWithHeart #ALSresearch #clinicaltrials #patientsfirst ... See MoreSee Less
View on Facebook

The ALS Therapy Development Institute (@ALSTDI) is proud to announce the 2022 Leadership Award recipients: @becky_mourey, @LoriLarHeller, @sandrawmarlowe , and @HerALSStory. http://www.als.net/news/leadership-awards-2022/

Fun fact: I wrote my obit last night
I lost a friend & was reading ab his amazing life
My daughter said "please don't make me write your obit mom-my heart can't take it"
She's right-why would I leave this chore to her?
I sent it to my bf & asked her to take care of this for us

What do you do when given the news that you have 2-5 years to live? Andrea, diagnosed at age 33 with ALS, decided she didn't want to "just wait around for this disease to kill me."

Load More